A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease

Immunology Letters

Volumn 103, Issue 1, 2006, Pages 68-74

  Hifumi, Emi ^a,b   Yamada, Yukiko ^a   Uda, Taizo ^a,b  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Catalytic antibody; Cleavage; Heavy chain; Helicobacter pylori; Urease

Indexed keywords

CATALYTIC ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HPU 2; PEPTIDE; UNCLASSIFIED DRUG; UREASE;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANTIBODY ISOLATION; ANTIGEN BINDING; ARTICLE; BETA CHAIN; CATALYSIS; ENZYME DEGRADATION; ENZYME STRUCTURE; HEAVY CHAIN; HELICOBACTER PYLORI; IMMUNOBLOTTING; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, CATALYTIC; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; EPITOPES; HELICOBACTER PYLORI; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; SUBSTRATE SPECIFICITY; UREASE;

EID: 31544438548     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.10.016     Document Type: Article

References (25)

1. J.R. Warren, and B. Marshall Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet i 1983 1273 1275
2. D.Y. Graham, H.M. Malaty, D.G. Evans, D.J. Evans Jr., P.D. Klein, and E. Adam Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status Gastroenterology 100 1991 1495 1501
3. M.R. Barer, T.S.J. Elliott, D. Berkeley, J.E. Thomas, and E.J. Eastham Cytopathic effects of Campylobacter pylori urease J Clin Pathol 41 1986 597
4. S. Hazell, and A. Lee Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers Lancet ii 1986 15 17
5. D.T. Smoot, H.L.T. Mobley, G.R. Chippendale, J.F. Lawison, and J.H. Resau Helicobacter pylori urease activity is toxic to human gastric epithelial cell Infect Immunol 58 1990 1992 1994
6. G.E. Buck Campylobacter pylori and gastroduodenal disease Clin Microbiol Rev 3 1990 1 12
7. S. Paul, D.J. Volle, C.M. Beach, D.R. Johnson, M.J. Powell, and R.J. Massey Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody Science 244 1989 1158 1162
8. A.M. Shuster, G.V. Gololobov, O.A. Kvashuk, A.E. Bogomolova, I.V. Smirnov, and A.G. Gabibov DNA hydrolyzing autoantibodies Science 256 1992 665 667
9. T.G. Kanyshkova, D.V. Semenov, D.Yu. Khlimankov, V.N. Buneva, and G.A. Nevinsky DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers FEBS Lett 416 1997 23 26
10. K. Matsuura, K. Yamamoto, and H. Sinohara Amidase activity of human Bence Jones proteins Biochem Biophys Res Commun 204 1994 57 61
11. S. Paul, L. Li, R. Kalaga, P. Wilkins-Stevens, F.J. Stevens, and A. Solomon Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones protein and VL fragment J Biol Chem 270 1995 15257 15261
12. K. Matsuura, and H. Sinohara Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond J Biochem 377 1996 587 589
13. S. Lacroix-Desmazes, A. Moreau, Sooryanarayana, C. Bonnemain, N. Stieltjes, and A. Pashov Catalytic activity of antibodies against factor VIII in patients with hemophilia Nature Med 5 1999 1044 1047
14. E. Hifumi, Y. Okamoto, and T. Uda Super catalytic antibody [I]: decomposition of targeted protein by its antibody light chain J Biosci Bioeng 88 1999 323 327
15. E. Hifumi, Y. Okamoto, and T. Uda How and why 41S-2 antibody subunits acquire the activities to catalyze decomposition of the conserved sequence of gp41 of HIV-1 Appl Biochem Biotech 83 2000 209 220
16. T. Uda, E. Hifumi, K. Ohara, and Y. Zhou Catalytic activity of antibody light chain to gp41: a consideration of refolding in relation to activation mechanism Chem Immunol 77 2000 18 32
17. E. Hifumi, Y. Mitsuda, K. Ohara, and T. Uda Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chain J Immunol Methods 269 2002 283 298
18. E. Hifumi, H. Kondo, Y. Mitsuda, and T. Uda Catalytic features of monoclonal antibody i41SL1-2 subunits Biotech Bioeng 84 2003 485 493
19. K. Hatiuchi, E. Hifumi, Y. Mitsuda, and T. Uda Endopeptidase character of monoclonal antibody i41-7 subunits Immunol Lett 86 2003 249 257
20. Y. Mitsuda, E. Hifumi, K. Tsuruhata, H. Fujinami, N. Yamamoto, and T. Uda Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant Biotechnol Bioeng 86 2004 217 225
21. Y. Ikeda, R. Fujii, K. Ogino, K. Fukushima, E. Hifumi, and T. Uda Immunological features and inhibitory effects on enzymatic activity of monoclonal antibodies against Helicobacter pylori urease J Ferment Bioeng 86 1998 271 276
22. R. Fujii, F. Morihara, K. Fukushima, T. Oku, E. Hifumi, and T. Uda A recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori associated disease Biotechnol Bioeng 86 2004 737 747
23. R. Fujii, F. Morihara, T. Oku, E. Hifumi, and T. Uda Epitope mapping and features of the epitope for MAbs inhibiting enzymatic activity of H. pylori urease Biotechnol Bioeng 86 2004 434 444
24. L.C. James, P. Roversi, and D.S. Tawfik Antibody multispecificity mediated by conformational diversity Science 299 2003 1362 1363
25. D. Pillet, M. Paon, I.I. Vorobiev, A.G. Gabibov, D. Thomas, and A. Friboulet Idiotypic network mimicry and antibody catalysis: lessons for the elicitation of efficient anti-idiotypic protease antibodies J Immunol Methods 269 2002 5 12